Cart
sales@molnova.com
Alsteropaullone
CAS No. 237430-03-4
Alsteropaullone ( 9-Nitropaullone;NSC 705701 )
Catalog No. M13686 CAS No. 237430-03-4
Alsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 192 | In Stock |
|
| 10MG | 309 | In Stock |
|
| 25MG | 525 | In Stock |
|
| 50MG | 752 | In Stock |
|
| 100MG | 1035 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlsteropaullone
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM.
-
DescriptionAlsteropaullone (9-Nitropaullone, NSC 705701) is a derivative of kenpaullone, ATP-competitive inhibitor of CDKs and GSK3β, inhibits Cdk1/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E and Cdk5/p25 with IC50 of 35, 15, 200 and 40 nM; exhibits specific antitumor activity against Group 3 medulloblastomas, causes inhibition of cell cycle-related genes, and down-regulation of MYC; inhibits the cytosolic degradation of β-catenin to alter the canonical Wnt signaling pathway in primary axis patterning, reduces tau phosphorylation.
-
Synonyms9-Nitropaullone;NSC 705701
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number237430-03-4
-
Formula Weight293.30
-
Molecular FormulaC16H11N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=CC=CC=C2C(NC3=C4C=C([N+]([O-])=O)C=C3)=C4C1
-
Chemical Name7,12-dihydro-9-nitro-indolo[3,2-d][1]benzazepin-6(5H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Soni DV, et al. Cell Cycle. 2004 Mar;3(3):349-57.
2. Lahusen T, et al. Mol Carcinog. 2003 Apr;36(4):183-94.
3. Schultz C, et al. J Med Chem. 1999 Jul 29;42(15):2909-19.
4. Faria CC, et al. Oncotarget. 2015 Aug 28;6(25):21718-29.
2. Lahusen T, et al. Mol Carcinog. 2003 Apr;36(4):183-94.
3. Schultz C, et al. J Med Chem. 1999 Jul 29;42(15):2909-19.
4. Faria CC, et al. Oncotarget. 2015 Aug 28;6(25):21718-29.
molnova catalog
related products
-
LY3405105
1-Piperidinecarboxylic acid, 4-[[5-methyl-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester is a novel CDK7 inhibitors.
-
KB-0742 dihydrochlor...
KB-0742 dihydrochloride is a potent, selective and orally inhibitor of ?CDK9.
-
ICEC 0942 hydrochlor...
ICEC 0942 (CT7001) is a potent, selective, orally active CDK7 inhibitor with IC50 of 41 nM, displays 15-fold selectivity over CDK2 (IC50=578 nM).
